Pfizer Inc (PFE)

51.59
+1.50(+2.99%)
After Hours
51.49
-0.10(-0.19%)
- Real-time Data
  • Volume:
    24,158,155
  • Day's Range:
    50.30 - 51.64
  • 52 wk Range:
    38.82 - 61.71

PFE Comments

What is your sentiment on Pfizer?
or
Market is currently closed. Voting is open during market hours.

All Comments

(7430)
  • see????
    0
    • No quick profits here, but 75$ looks likely after Q2 when most pill deliveries will kick in.
      1
      • For the short brains: https://www.investing.com/news/stock-market-news/pfizer-biontech-gain-on-pact-to-make-mrna-vaccine-for-shingles-2730933
        0
        • I am exiting, terrorism case seems too strong against them
          6
          • A lot of good news but the price is still down a bit more than I thought, the 3rd wave is very long but it was interrupted due to something. But I believe PFE will soon come back and break 60-61 to bounce to a new level.
            1
            • A lot of good news but the price is still down a bit more than I thought, the 3rd wave is very long but it was interrupted due to something. But I believe PFE will soon come back and break 60-61 to bounce to a new level.
              1
              • This looks like it will fall the same amount tomorrow. Nevertheless, I bought some more.
                0
                • If you check the news (right here at this website) about Pfizer, you'll see why you'd better buy it on pushbacks like today, instead of sell I like some geniuses keep telling since it was USD 30.00 per share:https://www.marketwatch.com/story/pfizer-doubles-sales-of-covid-19-pill-to-us-government-to-20-million-treatment-courses-2022-01-04?siteid=rss
                  1
                  • I agree, i think they gave revenue guidance for 2022 to $81-$82 billion solid increase. Here is guidence for the pill alone and it's only US "U.S. government had agreed to buy additional 10 million courses of its COVID-19 oral therapy, bringing the total order by the government to 20 million courses. The details of the expanded deal were not disclosed by the company. But for the first order of 10 million courses by the government in November, it had said it would pay Pfizer $5.29 billion" Base on this information this dip is a buying opportunity, nut ofcorse maybe you get cheaper.
                    0
                  • 49-50$ for next sell TP.
                    0
                • Let's see what will happen to the share price when the next earnings will be presented. I think the story will be different. Pfizer is on the watchlist among big founds that will in big time. FOMO in no time, it's a decent value proposition. Or what do you think guys, should investors keep to Tesla nowadays and drop valuations nonsense?
                  0
                  • Tesla, like other techs, is high volatility based purely on speculation and moment mood. Sure, they did great sales numbers, but nothing that can justify the stock prices. Pfizer, on the other hand, is making great results, buying other companies, has great fundaments but it is not a tech (NASDAQ) company. So...people that want to make quick (2 to 3 months) profits might get frustrated about it. But it is a way more asymmetric investment than TESLA.
                    0
                • Either some insiders selling or an attach from some desperate hedgefund, i guess we ll see in a couple of days. My personal target was 75 and I have been holding since 28. Fundamentally I see no changes in valuation, but markets are very vulnarable right now, so the shortselling attacks might very well work, so won't be surprised if we lose another 10-20%.
                  1
                  • but I saw many articles that show the price will reduce between $44 to $54
                    0
                • Well, I bought too early.
                  0
                  • Me too
                    0
                  • me too :((
                    0
                • New covid variant appears in the south of France ~ A new study, published in medRxiv, yields the results of the analyzes of 12 patients with SARS-CoV-positive who lived in the same geographical area of southeastern France. In the PCR tests performed on these patients, mutations were detected that showed an atypical combination. According to the researchers, the index case or patient zero returned from a trip in Cameroon. Analysis of these patients, mostly from Marseilles, revealed 46 mutations and 37 deletions resulting in 30 amino acid substitutions and 12 deletions. Fourteen amino acid substitutions, including N501Y and E484K, and 9 deletions are found in the peak protein. The University of Aix-Marseille, which is studying the new variant, calls it IHU.
                  0
                  • end of covid
                    0
                    • Just bought 4000 stocks
                      0
                      • I bought a lot from this today.
                        0
                        • this company is going to make so much money
                          0
                          • like buying it on sale $100 in 2022
                            0
                            • 70 March 1st
                              0
                              • What’s not to like about Pfizer. Come on!
                                1
                                • Potenial break out. But i believe it wont last.
                                  0
                                  • The UK report also strengthened the case for the Moderna booster, noting that protection against omicron was higher in those who received a Moderna booster after two Pfizer shots compared with those who received a third Pfizer shot. The Moderna booster was also slightly more effective than Pfizer for people who received two doses of the AstraZeneca vaccine.
                                    1
                                    • let's go magneting north $100 believe it
                                      0
                                      • To 70...
                                        0
                                        • I am buying BABA now. IMO PFE is good also, and will go up on long term even covid ends. BABA is more risky but has huge up potential.
                                          2
                                          • buy while it is cheap. it will go up again. cases are going up.
                                            0